Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: News Bites Pty Limited
|
$5.00
|
|
Provider: News Bites Pty Limited
|
$5.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
GlaxoSmithKline Pharmaceuticals Ltd Recommends Dividend
GlaxoSmithKline Pharmaceuticals Ltd announced that the Board of Directors of the Company at its meeting held on February 19, 2013, inter alia, has recommended a Dividend of INR50 per equity shares (Previous year : INR45 per equity share).
Latest Developments for GlaxoSmithKline Pharmaceuticals Ltd
Latest Key Developments in Pharmaceuticals
- AmerisourceBergen Corp Reaffirms FY 2013 EPS Gudiance-Conference Call
- Immunotec Inc Announces New CEO
- Novo Nordisk A/S Reports Positive Results from First Phase 3 Trial with Long-Acting Factor IX for Treatment of Haemophilia B
- Sanofi SA Announces Positive Results on Pivotal Study of Inhibitor in Myelofibrosis-DJ
- Share this
- Link this
- Digg this
Follow Reuters